Vimentin is a novel AKT1 target mediating motility and invasion
Open Access
- 20 September 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 30 (4), 457-470
- https://doi.org/10.1038/onc.2010.421
Abstract
The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.Keywords
This publication has 41 references indexed in Scilit:
- Recruitment of vimentin to the cell surface by β3 integrin and plectin mediates adhesion strengthJournal of Cell Science, 2009
- Identification of Phosphorylation-Induced Changes in Vimentin Intermediate Filaments by Site-Directed Spin Labeling and Electron Paramagnetic ResonanceBiochemistry, 2008
- Metastasis Suppressors and the Tumor MicroenvironmentCancer Microenvironment, 2008
- Phosphorylation of Human Insulin Receptor Substrate-1 at Serine 629 Plays a Positive Role in Insulin SignalingEndocrinology, 2007
- Akt1 governs breast cancer progression in vivoProceedings of the National Academy of Sciences of the United States of America, 2007
- Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional ActivityPublished by Elsevier BV ,2007
- Akt1 Ablation Inhibits, whereas Akt2 Ablation Accelerates, the Development of Mammary Adenocarcinomas in Mouse Mammary Tumor Virus (MMTV)-ErbB2/Neu and MMTV-Polyoma Middle T Transgenic MiceCancer Research, 2007
- Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycinCancer Cell, 2006
- Protein kinase A phosphorylates and regulates dimerization of 14‐3‐3ζFEBS Letters, 2005
- PKCɛ-mediated phosphorylation of vimentin controls integrin recycling and motilityThe EMBO Journal, 2005